Nasdaq

RECELL® System Data Presented at American Burn Association Fall Regional Burn Conferences

Carney. A Pilot Study of Negative Pressure Therapy with Autologous Skin Cell Suspensions in a Porcine Model. Presented at Northeast Region Burn Conference; 2020 November 6; Virtual. Desai. Aesthetic ...
Nasdaq

AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food and Drug Administration for Treatment of Vitiligo

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)-- AVITA Medical Limited (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet ...
FOX40 News

RECELL® System Data to be Presented at the Controversies and Conversations in Laser & Cosmetic Surgery Annual Meeting

VALENCIA, Calif. and MELBOURNE, Australia, Aug. 17, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a ...
Business Wire

First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL® System for Pediatric Scald Injuries

The RECELL System is indicated for use in the treatment of acute thermal burns in patients 18 years and older. The RECELL System is used to prepare Spray-On Skin™ Cells using a small amount of a ...
Healio

Recell system under study for soft-tissue reconstruction

Please provide your email address to receive an email when new articles are posted on . Enrollment in a trial to evaluate the Recell system for soft-tissue reconstruction has been completed, according ...
Business Wire

First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical ...
Monthly Prescribing Reference

RECELL System Cleared for Skin Repigmentation in Patients With Vitiligo

Credit: Avita Medical. The RECELL System is a single-use, autologous cell harvesting device. The Food and Drug Administration (FDA) has approved the RECELL ® System for the treatment of vitiligo. The ...
Healio

Recell system for extensive burns approved for use in children

Please provide your email address to receive an email when new articles are posted on . The FDA has expanded its approval of the Recell system in combination with meshed autografting to include ...
WDAF-TV

AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization ...
Monthly Prescribing Reference

RECELL System Approved to Treat Full-Thickness Skin Defects

Credit: Avita Medical. The RECELL System is a single-use, autologous cell harvesting device. The Food and Drug Administration (FDA) has expanded the approval of the RECELL ® System to include ...
The Globe and Mail

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment

VALENCIA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company, today announced ...
Business Insider

RECELL® System Data Presented at American Burn Association Fall Regional Burn Conferences

Abstracts Highlighting Clinical and Health Economic Data Reinforce Effectiveness of Treatment with RECELL System More than 10,000 Patients treated with RECELL System globally VALENCIA, Calif. and ...